Appeals court blocks launch of generic Aciphex

07/22/2008 | Bloomberg1

The U.S. Court of Appeals for the Federal Circuit rejected an appeal from Dr. Reddy's Laboratories and Teva Pharmaceutical Industries that challenged Eisai's patent for Aciphex, a treatment for stomach ulcer. The decision prohibits the generic-drug firms from making their versions until the patent expires in May 2013.

View Full Article in:

Bloomberg1

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA